Detailed price information for Nektar Therapeutics (NKTR-Q) from The Globe and Mail including charting and trades.
Picture a vessel the length of two and a half football fields, loaded with 80,000 tons of grain. It is crossing the open Pacific, its engine running, yet something else is doing part of the work. Two ...
PYXS’ micvotabart pelidotin faces head & neck cancer competition, side effects and funding risk. See fall 2026 catalyst, ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pyxis Oncology (PYXS) and Glaukos (GKOS) with bullish sentiments. Unlock powerful investing tools and ...
From cutting energy costs to unlocking new markets, see how companies in Singapore are proving that going green is a long-term driver for growth and resilience. Read more at straitstimes.com. Read ...
Expected to extend cash runway into the second quarter of 2027, supporting additional follow-up for 2L+ R/M HNSCC patients treated with MICVO at or below a dose cap Company now expects updated Phase 1 ...
Access detailed historical stock prices, including daily closing prices, for PYXS. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...
Muhsin discussed how BD is rolling out a new medication dispenser and a software platform that pulls together data from the company’s various devices.
Maroussi, Greece – June 24, 2026 – Pyxis Tankers Inc. (Nasdaq Capital Market: PXS) (the "Company" or "Pyxis Tankers"), an international shipping company, today provided an operational update regarding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results